Skip to main content

METRONIDAZOLE

Tracking # 20-838081

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

METRONIDAZOLE IS ONE OF THE MAINSTAY DRUGS FOR THE TREATMENT OF ANAEROBIC BACTERIAL INFECTIONS, PROTOZOAL INFECTIONS, AND MICROAEROPHILIC BACTERIAL INFECTIONS. IT IS CYTOTOXIC TO FACULTATIVE ANAEROBIC MICROORGANISM. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS PERTINENT TO MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE CARE OF PATIENTS BEING TREATED WITH THIS MEDICATION.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1.5h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1.5h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1.5h AMA Category I

Physician Assistant

1.5h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1.5h AMA Category I